Today’s Solutions: October 01, 2022

While humans tend to have a natural aversion to virtually all of nature’s venomous creatures, one popular arachnid may hold key to unlocking a painkiller that rivals opioids in effectiveness, but without the damaging side-effects, such as addiction.

A team of researchers from the University of Queensland has developed a mini-protein from tarantula venom that will potentially be able to relieve chronic pain, without the unwanted side-effects of opioid-based painkillers, which can have adverse reactions such as nausea, constipation, and a high risk of addiction.

Called Huwentoxin-IV, the mini-protein is found in the venom of a type of tarantula known as the Chinese bird spider, native to southern China and Vietnam.

The researchers altered the protein, enhancing its already-existing ability to bind with specific pain receptors in the body, thus blocking the perception of pain. Because the resulting drug is so potent and precisely-targeted, relatively little of it is required, minimizing any potential side effects.

Solutions News Source Print this article
More of Today's Solutions

Five steps for making your clothes last as long as possible

The clothes we wear can make us feel confident and help us express our inner selves. Unfortunately, our culture of fast fashion produces these ...

Read More

Resistance training fights muscle loss. Here are 3 ways to do more of it

We've know for a while that resistance training is key to longevity and health.  In a recent study, researchers found that resistance training was ...

Read More

This composting technique turns food waste into fertilizer in just 24 hours

Composting organic waste is a great way to prevent it from ending up in landfills and releasing methane, a greenhouse gas a lot more ...

Read More

As the weather warms up, here’s how to help animals handle a heatwave

Right now, much of Europe and North America are experiencing ongoing heatwaves with record-breaking temperatures.  It’s not just humans that are struggling to cope. ...

Read More